719: Da vinci x robotic breast surgery- redefining cosmetic excellence- Soundarya Satyabhama
This is one of the entries accepted for adjudication for the 2026 KS Innovation Awards, sponsored by the Vattikuti Foundation. Posting here does not imply being a Finalist.
Here is the Abstract:
Da vinci x Robotic lumpectomy in benign breast disease –
Redefining cosmetic excellence
Dr Soundarya Satyabhama
St. John’s medical college and hospital
bangalore, india
soundarya@gmail.com
Introduction
Benign breast lesions commonly affect young women, for whom
preservation of breast aesthetics is an important component of
surgical care. Conventional lumpectomy may result in visible
scarring, contour deformity, and asymmetry. Robotic breast
surgery offers a remote-access approach that conceals the incision
while enabling precise excision and preservation of breast
aesthetics.
Purpose
To evaluate the safety, feasibility, cosmetic outcomes, and patient
satisfaction of Da Vinci X robotic-assisted lumpectomy via a
remote axillary incision in women with benign breast disease.
Methods
A prospective analysis of 50 consecutive women undergoing
robotic excision of benign breast lumps was conducted at a single
institution. Only patients with ultrasound- and FNAC-proven
benign breast lesions measuring 1–3 cm were included. Robotic
lumpectomy was performed using the Da Vinci X surgical system
through a remote axillary incision. Perioperative outcomes,
complications, and cosmetic outcomes were assessed. Patient-
reported outcomes were evaluated using the BREAST-Q
questionnaire.
Results
All 50 patients underwent successful robotic excision without
conversion to open surgery. Histopathology revealed
fibroadenoma in 43 patients (86%), fibrocystic disease in 5
(10%), and papilloma in 2 (4%). The median hospital stay was
one day, with return to normal activity within two weeks.
Complications occurred in 12 patients (24%), with no reported
long-term sequelae. BREAST-Q scores demonstrated high patient
satisfaction, with breast satisfaction and psychosocial well-being
scores of 88/100 and 82/100, respectively.
Conclusion
Robotic surgery for benign breast disease via a remote axillary
incision using the Da Vinci X robot is a safe, reproducible
technique that provides high patient satisfaction and improved
cosmetic outcomes.